TVGNW — Tevogen Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1860871 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -5,662,376 -5,761,940 4,727,741 1,082,155 13,616,501
Mar 2026 0 — -5,400,920 -5,446,255 4,921,005 692,305 14,763,163
Dec 2025 0 — -4,610,201 -4,677,580 4,382,994 552,372 12,617,720
Sep 2025 0 — -5,729,431 -5,726,812 4,493,669 1,037,094 12,317,565

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-11,754,283
Investing CF
$0
Financing CF
$10,536,095
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-08-16

Balance + Analyst (yfinance extras)

Retained Earnings
$-145,106,804
Inventory
—
Receivables
$158,819
ST Investments
—
EBIT TTM
$-21,091,003
Pretax Income TTM
$-21,354,626
Interest Exp TTM
$228,751
Analysts
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -26,140,515 -26,275,432 4,382,994 12,617,720 -8,234,726 -12,328,577
Dec 2024 0 -53,564,488 -13,727,380 3,461,675 10,135,680 -6,674,005 -11,998,730
Dec 2023 0 -8,843,025 -60,477,680 5,505,503 99,934,400 -94,428,897 -8,171,118
Dec 2022 0 -953,083 4,408,361 357,138,356 15,057,704 342,080,652 -215,395
Dec 2021 — — — — — — —

Peers — same industry

TickerNameMarket CapLastDaily %
AMGN AMGEN INC $224.15B $414.61 —
GILD GILEAD SCIENCES, INC. $187.15B $150.93 —
MRNA Moderna, Inc. $79.40B $198.88 —
ARGX ARGENX SE $59.67B $959.49 —
RVMD Revolution Medicines, Inc. $43.93B $204.97 —

News headlines (Yahoo Finance, 1h cache)

Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
2026-03-26 16:45 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.